{
    "organizations": [],
    "uuid": "6c1f3d1cdb724a1784871bb855421661884b33ac",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zosano-pharma-announces-issuance-o/brief-zosano-pharma-announces-issuance-of-new-u-s-patent-covering-m207-as-an-acute-treatment-for-migraine-idUSFWN1QK0QR",
    "ord_in_thread": 0,
    "title": "BRIEF-Zosano Pharma Announces Issuance Of New U.S. Patent Covering M207 As An Acute Treatment For Migraine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2 (Reuters) - Zosano Pharma Corp:\n* ZOSANO PHARMA ANNOUNCES ISSUANCE OF NEW U.S. PATENT COVERING M207 AS AN ACUTE TREATMENT FOR MIGRAINE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-02T21:34:00.000+02:00",
    "crawled": "2018-03-03T17:32:09.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "zosano",
        "pharma",
        "corp",
        "zosano",
        "pharma",
        "announces",
        "issuance",
        "new",
        "patent",
        "covering",
        "m207",
        "acute",
        "treatment",
        "migraine",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}